Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,650,183
  • Shares Outstanding, K 142,873
  • Annual Sales, $ 154,340 K
  • Annual Income, $ -207,280 K
  • 60-Month Beta 0.99
  • Price/Sales 11.02
  • Price/Cash Flow N/A
  • Price/Book 3.28
Trade ADPT with:

Options Overview Details

View History
  • Implied Volatility 96.56% ( +3.48%)
  • Historical Volatility 81.96%
  • IV Percentile 65%
  • IV Rank 42.24%
  • IV High 157.26% on 03/14/22
  • IV Low 52.17% on 12/23/21
  • Put/Call Vol Ratio 15.50
  • Today's Volume 33
  • Volume Avg (30-Day) 78
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 3,785
  • Open Int (30-Day) 3,444

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.37
  • Number of Estimates 5
  • High Estimate -0.32
  • Low Estimate -0.41
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +7.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.39 +32.18%
on 07/26/22
13.21 -16.05%
on 08/11/22
+2.14 (+23.91%)
since 07/18/22
3-Month
5.95 +86.23%
on 06/14/22
13.21 -16.05%
on 08/11/22
+3.56 (+47.28%)
since 05/18/22
52-Week
5.95 +86.23%
on 06/14/22
40.00 -72.28%
on 09/07/21
-19.62 (-63.89%)
since 08/18/21

Most Recent Stories

More News
3 Cathie Wood Stocks for the Future

Unlike a lot of tech investors, Cathie Wood is super bullish on biotechnology. Here are three of her picks that these Motley Fool contributors love.

FATE : 29.62 (-1.95%)
VCYT : 22.54 (-0.18%)
ADPT : 11.01 (-4.68%)
Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript

ADPT earnings call for the period ending June 30, 2022.

ADPT : 11.01 (-4.68%)
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 7.50% and 0.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ADPT : 11.01 (-4.68%)
AKYA : 13.01 (-2.47%)
Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results

SEATTLE, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage...

ADPT : 11.01 (-4.68%)
Is a Surprise Coming for Adaptive Biotechnologies (ADPT) This Earnings Season?

Adaptive Biotechnologies (ADPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ADPT : 11.01 (-4.68%)
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?

Continued strength in BD's (BDX) Interventional segment is expected to have driven up Q3 sales.

BDX : 262.12 (-0.80%)
ADPT : 11.01 (-4.68%)
CNTA : 4.29 (+1.18%)
SGHT : 7.99 (-2.38%)
CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?

Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.

ALC : 68.62 (-0.07%)
CVS : 103.33 (-1.52%)
ANIP : 35.54 (-0.92%)
ADPT : 11.01 (-4.68%)
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma

clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in DLBCL...

ADPT : 11.01 (-4.68%)
Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022

SEATTLE, July 08, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial-stage biotechnology company that aims to...

ADPT : 11.01 (-4.68%)
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease

T-Detect Lyme enables patients and healthcare providers to detect early Lyme disease with greater sensitivity than leading antibody tests...

ADPT : 11.01 (-4.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 12.25
2nd Resistance Point 12.04
1st Resistance Point 11.80
Last Price 11.01
1st Support Level 11.35
2nd Support Level 11.14
3rd Support Level 10.90

See More

52-Week High 40.00
Fibonacci 61.8% 26.99
Fibonacci 50% 22.98
Fibonacci 38.2% 18.96
Last Price 11.01
52-Week Low 5.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar